UK Virus Update: Current Infections & Latest Information

As of early 2024, multiple respiratory and enteric viruses are co-circulating in the UK. Surveillance data (UKHSA, NHS) indicate:

Major Circulating Viruses

VirusCurrent ActivityKey FeaturesAt-Risk Groups
COVID-19 (SARS-CoV-2)Endemic; waves every 3-6 months. JN.1 variant dominant (winter 2023-24).Fever, cough, fatigue, anosmia; long COVID risk.Elderly, immunocompromised, unvaccinated, multimorbidity.
Influenza (Flu)Seasonal (Oct-Mar). 2023-24: moderate A(H1N1)pdm09 + B/Victoria.Abrupt fever, myalgia, headache, cough.≥65, <5, pregnant, chronic disease.
RSVSeasonal (Oct-Mar). High 2023-24; pediatric hospitalizations.Bronchiolitis in infants; cold-like in adults.Infants <1, preterm, CHD, CLD, elderly.
NorovirusYear-round; winter peaks. High 2023-24.Vomiting, diarrhea, nausea; 12-48h incubation.All ages; outbreaks in care homes, schools, hospitals.
Rhinovirus/EnterovirusYear-round; fall/spring peaks.Common cold; asthma exacerbations.Children, asthmatics.
AdenovirusSporadic; can cause conjunctivitis, pneumonia.Fever, pharyngitis, conjunctivitis, GI.Children, military recruits, immunocompromised.

Co-circulation & Co-infection

  • Simultaneous infection with ≥2 viruses occurs (e.g., COVID+flu, RSV+rhinovirus).
  • Co-infection may increase severity, especially in vulnerable populations.
  • Multiplex PCR panels (respiratory pathogen panels) enable detection.

Public Health Guidance (UKHSA/NHS)

  • Vaccination: COVID-19 autumn booster (eligible groups), annual flu vaccine, RSV vaccine (new: pregnant 28-36 wks, older adults 75-79), pneumococcal.
  • Hygiene: Handwashing, respiratory etiquette, surface cleaning.
  • Isolation: Stay home if febrile/unwell; 48h after norovirus symptoms cease.
  • Masking: In healthcare, crowded indoor spaces, if symptomatic.
  • Ventilation: Open windows, HEPA filters.

When to Seek Care

  • Difficulty breathing, chest pain, confusion, inability to maintain fluids.
  • High-risk individual with flu/COVID symptoms → early antiviral eligibility (oseltamivir, nirmatrelvir/ritonavir).
  • Infant <3 months with fever ≥38°C.

Check UKHSA surveillance reports for weekly updates.

Viral Infections - Related Articles